Company / Tangible Book Value per Share
Ventyx Biosciences, Inc. Tangible Book Value per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$3.71
FY2024
5-year range
-$15.41 / $21.77
FY2020-FY2024
Trend
-11.0%
vs FY2023
Sector context
#115 of 207
Health Care
What the data says
At $3.71, Ventyx Biosciences, Inc.'s tangible book value per share ranks #115 of 207 in the Health Care sector. Tangible Book Value per Share has declined for 3 consecutive years, from $21.77 in FY2021 to $3.71 in FY2024.
Based on SEC 10-K filings.
3.71 in FY2024 with a 3-year CAGR of -44.6%.
Declined from $6.74 to $3.71 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -44.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#115 of 207 in Health CareTop 56% of 207This company $3.71 Sector average $111.62
▼
-96.7% below sector average
Key checks
Key Insights
- Ventyx Biosciences, Inc.'s tangible book value per share has declined for 3 consecutive years.
- In FY2024, tangible book value per share decreased 11.0% year-over-year.
- Ranks #115 out of 207 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 3.63 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $3.71 | -11.0% |
| FY2023 | $4.17 | -38.2% |
| FY2022 | $6.74 | -69.0% |
| FY2021 | $21.77 | +241.2% |
| FY2020 | -$15.41 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026